Doxacurium Chloride | Interleukin Related interleukin-related.com

Product Name :
Doxacurium Chloride

Search keywords :
Doxacurium (chloride)

drugId :
null

Target Vo:
Muscarinic acetylcholine receptor M2

Target Vo Short Name :
CHRM2

Moa_Name:
Muscarinic acetylcholine receptor M2 antagonists

First Approval Country :
United States

First Approval Date Filter:
1991

Origin Company_Name :
Abbvie Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Anesthesia

Termination Status :

China Termination Status :

Highest Status:
Withdrawn

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
OPA1 Antibody
Casein Kinase 2 beta Antibody
BNIP3L Antibody: BNIP3L Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 24 kDa, targeting to BNIP3L. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts